83 related articles for article (PubMed ID: 17121216)
1. [Resistance to HIV-1 infection of CD4 + T lymphocytes in vitro from chinese HIV-1 exposed seronegative individuals].
Su YL; Shang H; Liu J; Wang SX; Geng WQ; Cui HL; Jiang YJ; Wang YN; Zhang ZN; Wang YT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):613-7. PubMed ID: 17121216
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.
Alimonti JB; Koesters SA; Kimani J; Matu L; Wachihi C; Plummer FA; Fowke KR
J Infect Dis; 2005 Jan; 191(1):20-4. PubMed ID: 15592998
[TBL] [Abstract][Full Text] [Related]
3. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use.
Camara M; Dieye TN; Seydi M; Diallo AA; Fall M; Diaw PA; Sow PS; Mboup S; Kestens L; Jennes W
J Infect Dis; 2010 Mar; 201(6):835-42. PubMed ID: 20136413
[TBL] [Abstract][Full Text] [Related]
4. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO+CD4+ T lymphocytes.
Holl V; Schmidt S; Aubertin AM; Moog C
Arch Virol; 2007; 152(3):507-18. PubMed ID: 17122895
[TBL] [Abstract][Full Text] [Related]
5. High plasma activity of endogenous antioxidants protect CD4+ T-cells in HIV-serodiscordant heterosexual partners in a Nigerian population.
Ibeh BO; Obidoa O; Uzoegwu PN
Int J STD AIDS; 2008 Aug; 19(8):536-40. PubMed ID: 18663040
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans.
Kebba A; Kaleebu P; Serwanga J; Rowland S; Yirrell D; Downing R; Gilmour J; Imami N; Gotch F; Whitworth J
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):67-75. PubMed ID: 15000700
[TBL] [Abstract][Full Text] [Related]
7. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
[TBL] [Abstract][Full Text] [Related]
8. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
10. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis as a mechanism of natural resistance to HIV-1 infection in an exposed but uninfected population.
Velilla PA; Hoyos A; Rojas M; Patiño PJ; Vélez LA; Rugeles MT
J Clin Virol; 2005 Apr; 32(4):329-35. PubMed ID: 15780814
[TBL] [Abstract][Full Text] [Related]
12. [The effect of specific virus delivering of Langerhans cell for the M-tropic HIV infection].
Shi WM; Cameron PU; Purcell DJ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1442-6. PubMed ID: 14521751
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
Haponsaph R; Darden JM; Chantakulkij S; Sannoi N; de Souza MS; Brown AE; Birx DL; Polonis VR; Pattanapanyasat K
Asian Pac J Allergy Immunol; 2004 Mar; 22(1):39-48. PubMed ID: 15366657
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
15. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
[TBL] [Abstract][Full Text] [Related]
16. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
17. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients.
Schenal M; Lo Caputo S; Fasano F; Vichi F; Saresella M; Pierotti P; Villa ML; Mazzotta F; Trabattoni D; Clerici M
AIDS; 2005 Apr; 19(7):653-61. PubMed ID: 15821391
[TBL] [Abstract][Full Text] [Related]
19. Commitment to apoptosis in CD4(+) T lymphocytes productively infected with human immunodeficiency virus type 1 is initiated by lysosomal membrane permeabilization, itself induced by the isolated expression of the viral protein Nef.
Laforge M; Petit F; Estaquier J; Senik A
J Virol; 2007 Oct; 81(20):11426-40. PubMed ID: 17670831
[TBL] [Abstract][Full Text] [Related]
20. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
